Table 3.
Genotype distribution of EGF +61A/G polymorphism in different control populations reported in different case-control studies n (%)
| n |
Genotype |
|||
| AA | AG | GG | ||
| Asia | ||||
| Jin et al[30] | 660 | 57 (8.6) | 289 (43.8) | 314 (47.6) |
| Goto et al[31] | 454 | 47 (10.4) | 188 (41.8) | 215 (47.8) |
| Hamai et al[29] | 230 | 25 (10.9) | 97 (42.1) | 108 (47.0) |
| Europe | ||||
| Portugal (our data) | 984 | 304 (30.9) | 449 (45.6) | 231 (23.5) |
| Shahbazi et al[10] | 99 | 32 (32.3) | 47 (47.5) | 20 (20.2) |
| McCarron et al[32] | 310 | 121 (39.0) | 131 (42.3) | 58 (18.7) |
| Costa et al[34] | 570 | 173 (30.3) | 266 (46.7) | 131 (23.0) |
| Australia | ||||
| James et al[33] | 2646 | 883 (33.4) | 1317 (49.8) | 446 (16.9) |